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The ureogenic action of epinephrine in hepatocytes from normal adult rats is mediated through activation 
of ai-adrenoceptors. ,&Adrenoceptors in addition to cui-adrenoceptors, became involved in mediating this 
effect in cells from animals treated with pertussis toxin. The accumulation of cyclic-AMP in response to 
epinephrine or isoproterenol was markedly increased in hepatocytes from pertussis-treated rats as 
compared to that observed in control cells. The accumulation of cyclic-AMP due to glucagon was also 
increased. It is suggested that pertussis toxin may release a constraint on adenylate cyclase activity by 
blocking the inhibitory coupling mechanism (Ni) or some other entity involved in the regulation of the 
activity of this enzyme. 
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1. INTRODUCTION 
Three types of adrenoceptors are present in rat 
hepatocytes; i.e., ai-, CYZ- and &adrenoceptors 
[ 1,2]. These adrenoceptor subtypes are coupled to 
different mechanisms of signal transduction: ,& 
adrenergic activation results in the stimulation of 
adenylate cyclase whereas cu2-adrenergic a tivation 
results in inhibition [3,4]; the mechanism of signal 
transduction for at-adrenergic amines is not well 
known, but it seems to involve a calcium signalling 
system associated to phosphatidylinositol turnover 
[3,5] and other unknown factors [6]. 
al-Adrenoceptors are the main mediators of the 
metabolic actions of epinephrine in hepatocytes 
from normal adult rats [5,7-g]; the physiological 
significance of cuz-adrenoceptors in rat hepatocytes 
is unknown and ,&-adrenoceptors eem to play, if 
any, a minor role. However, there are certain 
physiological conditions in which&-adrenoceptors 
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become involved in mediating the metabolic actions 
of epinephrine in liver cells. Thus,,&-adrenoceptors 
are involved in the actions of epinephrine in hepato- 
cytes from fetal [lo], juvenile [l l-131, hypothy- 
roid [6,14,15] or adrenalectomized rats [16,17]. 
,&-Adrenoceptors also play significant roles in the 
hepatic actions of catecholamines during cholesta- 
sis [ 181 and in hepatocytes formed during the initial 
stages of liver regeneration after partial hepatec- 
tomy [19]. 
Pertussis toxin, a protein isolated from the cul- 
ture medium of Bordetella pertussis, markedly de- 
creases receptor-mediated inhibitions of adenylate 
cyclase and magnifies stimulations of this enzyme 
in some cells [20-241. Furthermore, we have ob- 
served that the administration of pertussis toxin to 
rats markedly diminishes in their adipocytes the 
cyi -adrenergic-mediated stimulation of phosphati- 
dylinositol labeling [25]. 
This study describes the effect of pertussis toxin 
on the sensitivity of adult rat hepatocytes to ad- 
renergic amines, glucagon, vasopressin and angio- 
tensin II. 
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2. MATERIALS AND METHODS 
The sources of materials were as in [6,9,12,19]. 
Pertussis toxin was isolated from pertussis vaccine 
concentrates generously provided by the National 
Institute of Hygiene of Mexico. The toxin was puri- 
fied about 2000-fold by gel filtration, adsorption 
and ion-exchange chromatography [21]. Female 
Wistar rats were injected intraperitoneally with 
15 pg toxin/l00 g body wt in a single dose, 3 days 
before the experiment was performed. The effects 
of the toxin lasted for at least 1 week. Hepatocytes 
were isolated and incubated as in [9]. Urea, cyclic- 
AMP and phosphatidylinositol abeling were as- 
sayed as in [6,9,19]. 
3, RESULTS 
Epinephrine stimulated ureogenesis in a dose- 
dependent fashion in hepatocytes from control rats 
(fig.l). In agreement with our previous report [9], 
the ,&adrenergic agonist isoproterenol was without 
effect on ureogenesis (fig.l), and the action of 
epinephrine was blocked by the cur-adrenergic- 
selective antagonist, prazosin (fig.2). Interestingly, 
in hepatocytes from pertussis toxin-treated rats, 
the dose-response to epinephrine was slightly 
shifted to the left as compared to the control (fig. 1) 
and isoproterenol produced a clear dose-dependent 
stimulation of ureogenesis in these cells (fig.2) 
which was blocked by propranolol (not shown). 
Consistent with these findings, the stimulation of 
ureogenesis produced by epinephrine in cells from 
treated rats was not blocked by either propranolol 
or prazosin alone, but it was blocked in the pre- 
sence of both antagonists (fig.2). The results indi- 
cate that both al- andfl-adrenoceptors are involved 
in the actions of epinephrine in hepatocytes from 
pertussis toxin-treated rats. 
The stimulation of ureogenesis produced through 
activation of cyr -adrenoceptors in hepatocytes 
from control and pertussis toxin-treated rats were 
very similar (epinephrine plus propranolol col- 
umns, fig.2). To further evaluate the al-adrenergic 
sensitivity of the cells, the action of epinephrine on 
phosphatidylinositol abeling was studied. It was 
observed that this cur-adrenergic action of epine- 
phrine was not affected by the administration of 
pertussis toxin (fig.3). The effects of the calcium- 
dependent hormones, vasopressin and angiotensin 
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Fig. 1. Dose-response curves to epinephrine and isopro- 
terenol. Hepatocytes were incubated in 1 ml Krebs- 
Ringer-bicarbonate buffer containing 1% albumin, 
10 mM glucose, 10 mM glutamine and 2 mM ornithine 
for 60 min at 37’C. Basal ureogenesis was 26 f 3 and 
24 * 4 nmol/mg cell wet wt in cells from control and 
toxin-treated rats, respectively. Results are the means, 
and vertical bars represent SEM of 6-8 expt performed 
in duplicate. 
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Fig.2. Effect of epinephrine and adrenergic antagonists 
on ureogenesis: lo-’ M epinephrine (EPI); 10m5 M 
prazosin (PRAZ); 10m5 M propranolol (PROP). Other 
indications as in fig.1. 
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Fig.3. Effect of epinephrine on the labeling of phospha- 
tidylinositol. Cells were incubated in the medium des- 
cribed in fig.1, supplemented with 10&i of j2Pi. Basal 
incorporation of label into phosphatidylinositol was 
2160 f 330 and 1920 f 360cpm/lO mg cell wet wt in 
cells from control and toxin-treated rats, respectively. 
Other indications are as in fig.1. 
II, on ureogenesis and phosphatidylinositol labeling 
[26] were not affected by the administration of per- 
tussis toxin (not shown). 
To further evaluate the ,8-adrenergic sensitivity 
of hepatocytes from persussis toxin-treated rats, 
the accumulation of cyclic-AMP in response to 
epinephrine or isoproterenol was studied. It was 
observed that the accumulation of cyclic-AMP due 
to P-adrenergic activation reached a higher maxi- 
mum in cells from treated animals as compared to 
the controls; however, the ECso was similar for 
both conditions. Interestingly, the accumulation of 
the cyclic nucleotide due to glucagon also reached 
a higher maximum in cells from pertussis toxin- 
treated rats as compared to that in the controls 
(fig.4). 
Experiments were performed to determine the 
az-adrenergic sensitivity of hepatocytes from 
treated animals and compare such sensitivity with 
that in the control cells. However, no consistent 
effect on cyclic-AMP levels was produced by 
a~-adrenergic activation in cells from either con- 
trol or treated animals. Similar difficulties in 
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Fig.4. Effect of epinephrine, isoproterenol or glucagon 
on cyclic-AMP accumulation. Cells were incubated in 
the buffer described in fig. 1, supplemented with 1OOpM 
theophylline. Incubations were stopped 2min after the 
addition of the agents. Other indications are as in fig. 1. 
demonstrating cuz-adrenergic effects on whole cells 
have been reported in [ 131. 
4. DISCUSSION 
Administration of pertussis toxin enhances the 
fl-adrenergic responsiveness of rat liver cells, as 
evidenced by the increased accumulation of cyclic- 
AMP in response to epinephrine or isoproterenol. 
It is interesting to note that in cells from control 
rats both adrenergic agonists consistently produced 
50-759’0 increases in cyclic-AMP levels (proprano- 
lol-sensitive). However, such increases in the level 
of the cyclic nucleotide do not seem to be metaboli- 
cally significant, at least when ureogenesis is the 
metabolic parameter measured; i.e., isoproterenol 
increases cyclic-AMP levels but is not effective in 
stimulating ureogenesis and the effect of epine- 
phrine on ureogenesis is totally blocked by prazo- 
sin, but not its action on cyclic-AMP. 
The increased /3-adrenergic responsiveness of 
liver cells from pertussis toxin-treated animals is 
reflected both in cyclic-AMP accumulation and in 
ureogenesis. The effect of pertussis toxin, how- 
ever, does not seem to be exclusive for the actions 
of fl-adrenergic amines; maximal accumulation of 
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q&e-AMP due to glucagon is also enhanced in 
cella from treated animals. The main action of per- 
t&r toxin seems to be to block the action of 
receptors coupled inhibitorily to adenylate cyclase 
[20-241. However, we have observed that the 
action of agents that stimulate adenylate cyclase 
through receptor-mediated processes, such as 
isoproterenol or ACTH in hamster fat cells is en- 
hanced in cells from pertussis toxin-treated animals 
[21]. Similar enhancements by pertussis toxin of 
receptor-mediated activations of adenylate cyclase 
have been observed in other cells [22-241. Further- 
more, we have observed that the accumulation of 
cyclic-AMP produced by forskolin is also magni- 
fied in cells from pertussis-toxin treated hamsters 
1211. Our interpretation of the results is that either: 
-6) 
(ii) 
The basal-activity of the inhibitory coupling 
mechanism (Ni) maintains a constraint on 
adenylate cyclase, and that such constraint is 
released by the action of the toxin; or 
That pertussis toxin may affect entities involved 
in the mechanism of activation of the enzyme. 
Administration of pertussis toxin to rats mar- 
kedly diminished the responsiveness of their adipo- 
cytes to ar-adrenergic activation, as reflected by a 
decreased stimulation of phosphatidylinositol a- 
beling by epinephrine [25]. In liver cells from per- 
tussis toxin-treated rats, al -adrenergic responsive- 
ness does not seem to be affected. Authors in [27] 
observed that the administration of pertussis toxin 
to rats diminishes the activation of liver phosphor- 
ylase by the subcutaneous administration of 
epinephrine. These authors suggested that the 
hyperinsulinism caused by pertussis vaccine can ac- 
count for the attenuated activation of phos- 
phorylase and hyperglycemia produced by epine- 
phrine. Our results indicate that the adrenergic 
sensitivity of hepatocytes of pertussis toxin-treated 
rats is not diminished, but actually increased (,&- 
adrenergic component), and support the sugges- 
tion that the hyperinsulinism might explain the 
results obtained in [27] in whole animals. 
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